From Progress to Plateau: Democrats’ Shifting Gains on Cannabis Reform

1.3 min readPublished On: November 5th, 2024By

LOS ANGELES- The Biden administration has a significant record on cannabis reform, characterized by policy shifts that have altered federal attitudes toward legalization. President Biden’s notable moves include an October 2022 executive action urging agencies to reconsider cannabis’ status under federal law, which led to recommendations to reclassify cannabis from a Schedule I to a Schedule III substance. This marked the most substantial change in federal cannabis regulation since 1970, signaling progressive intent. Despite these efforts, marijuana reform has lost its former potency as a political wedge issue.

Biden’s reforms, including pardons for nonviolent cannabis offenses, showcased his administration’s focus on social justice. However, the push for full legalization has faced obstacles, including Congressional gridlock and varying support even within the Democratic Party. For example, Senate Majority Leader Chuck Schumer’s efforts to leverage Biden’s reclassification for broader reform met with limited legislative traction due to bipartisan and intraparty challenges.

The waning impact of cannabis as a rallying point is attributed to shifting public sentiment; while support for legalization is strong, it no longer galvanizes voters as it once did. Analysts have observed that while Biden’s steps are historically significant, the opportunity to maximize their political advantage may have been missed, particularly as bipartisan interest in cannabis reform persists but lacks consistent legislative follow-through.

Vice President Harris’ advocacy has also been scrutinized, reflecting her mixed legacy on cannabis from her time as a prosecutor to her more progressive stance in the Senate. The Biden administration’s cautious approach and intra-party divides have contributed to this complex landscape, limiting potential political gains from these historic measures

About the Author: HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!